Skip to main content

Advertisement

Table 2 The characteristics of the cohort (IQR = interquartile range)

From: Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings

Total number of patients   5 197
Patient months Overall
On ART
136 672
116 306 (85%)
Duration on ART (months) Median
IQR
19
(10 to 32)
Age at starting ART (years) Median
IQR
37.3 years
(32.4 to 42.9)
Sex Female
Male
6 379(59.%)
4 356 (41%)
Patient status at end of study period Active
Left the scheme
Dead
2 922 (56%)
1 834 (34%)
421 (8%)
Baseline CD4+ cell count Median
IQR
87 cells/μL
(37 to 145)
Baseline viral load (log10) Median
IQR
5.22
(4.73 to 5.63)
NNRTI used in first line Nevirapine
Efavirenz
2 655 (26%)
6 711 (74%)
NRTI combination in first line Zidovudine + lamivudine
Stavudine + lamivudineother
other
3 339 (65%)
1 225 (24%)
633 (11%)
Duration of CD4+ cell count monitoring before starting ART (months) Median
IQR
1.2
(0.6 to 2.6)
Overall Adherence as measured by monthly pharmacy refill data Median
IQR
74.4%
(38.4 to 92.3)
  1. IQR=Interquartile Range